Previous epidemiological studies have shown that higher plasma or serum Gal-3 levels were associated with increased risks of incident CKD and rapid renal function decline, even with accounting for known clinical CKD predictors [13,14,15]. The gene discussed is LGALS3; the disease is chronic kidney disease.